360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Pharmaceutical Benefits Advisory Committee

Type: Organization

Name: Pharmaceutical Benefits Advisory Committee

First reported 20 hours ago - Updated 20 hours ago - 1 reports

infliximab

Medicines and the media: news reports of medicines recommended for government reimbursement in Australia

Previous analyses of the listings of trastuzumab on the Australian Pharmaceutical Benefits Scheme (PBS) and HPV vaccine on the National Immunisation Program (NIP) suggest a media influence on policy makers. We examined the timing and content of Australian ... [Published BMC - 20 hours ago]

Entities: Pharmaceutical Benefits Advisory Committee, Pharmaceutical Benefits Scheme, Pemetrexed, infliximab

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Glaucoma Management: Real Issues Yet To be...

An action plan is keenly awaited by eye care professionals who met with the Optometry Board of Australia (OBA) at the offices of the Australian Health Practitioner Regulation Agency (AHPRA) on 24 May to discuss the OBA’s decision to allow therapeutically ... [Published Mivision - May 20 2013]

Entities: Glaucoma, Patient, Australia, Pharmaceutical Benefits Advisory Committee, Pharmaceutical Benefits Scheme

First reported May 20 2013 - Updated May 20 2013 - 1 reports

Public Broadcasting Service

Price disclosure delivers for Government

20 May, 2013 Nick O'Donoghue commentsPrice Disclosure is expected to deliver almost 70% of the $18 billion of savings the Government is expected to gain through PBS reforms by 2017/18, a new report reveals.The Impact of Further PBS Reforms report compiled ... [Published Pharmacy News - May 20 2013]

Entities: Public Broadcasting Service, Reformism, Australia, Kate Lynch, Brendan Shaw

First reported May 19 2013 - Updated May 20 2013 - 2 reports

Patients missing out on medication, say drug companies

Drug companies have accused the Gillard government of denying patients the latest medicines, with the number of new medicines being added to the Pharmaceutical Benefits Scheme at a 20-year low.A report commissioned by the pharmaceutical industry shows ... [Published Sydney Morning Herald - May 20 2013]

Entities: Pharmaceutical Benefits Scheme, Drugs, Pharmaceutical Benefits Advisory Committee

First reported May 14 2013 - Updated May 15 2013 - 1 reports

GlaxoSmithKline plc

Bitter pill for GSK profits

GlaxoSmithKline has blamed a decline in the local pharmaceutical industry for an 8 per cent dip in its Australian profit.The subsidiary reported a net profit of $35 million for the 2012 calendar year, down from $38 million the year before.The results ... [Published Melbourne Age - May 14 2013]

Entities: GlaxoSmithKline plc, Geoff McDonald, Australia, Clinical trials, Pharmaceutical Benefits Advisory Committee

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Grampians' group echoes abortion pill PBS calls

Women's Health Grampians has joined calls for the abortion pill RU486 to be added to the Pharmaceutical Benefits Scheme (PBS).It took part in the Pharmaceutical Benefits Advisory Committee submission that recommends the cost of the pill be subsidised ... [Published ABC Online - May 14 2013]

Entities: Pharmaceutical Benefits Scheme, Pharmaceutical Benefits Advisory Committee, Melbourne, Abortion

First reported May 13 2013 - Updated May 13 2013 - 1 reports

Pharmacy history now on the net

As part of its celebrations of Pharmacy History Week, eager members of the Society of Hospital Pharmacists of Australia (SHPA) have recorded the achievements of leading pharmacists for posterity.During the pharmacy history celebrations last week, SHPA ... [Published Pharmacy News - May 13 2013]

Entities: Pharmaceutical Benefits Advisory Committee, Pharmacist, Wikipedia, Australian Pharmaceutical Industries Ltd

First reported Apr 29 2013 - Updated Apr 29 2013 - 1 reports

PBAC recommendation no guarantee of PBS-listing for Pradaxa

29 April, 2013 Kirrilly Burton and Nick O'Donoghue commentsA recommendation for the PBS-listing of Pradaxa (dabigatran), by the Pharmaceutical Benefits Advisory Committee (PBAC) – for the third time – is no guarantee the anticoagulant will be subsidised, ... [Published Pharmacy News - Apr 29 2013]

Entities: Pharmaceutical Benefits Advisory Committee, Pradaxa, Public Broadcasting Service, Anticoagulant

First reported Apr 28 2013 - Updated Apr 28 2013 - 2 reports

Australia 'pays too much for drug'

The federal government is wasting $260 million every year because it is ignoring advice from its own experts that it is paying too much for the most commonly prescribed drug in Australia.Health economists and consumer groups say the government must tackle ... [Published Melbourne Age - Apr 28 2013]

Entities: Drugs, Australia, Lipitor

First reported Apr 28 2013 - Updated Apr 28 2013 - 1 reports

Abortion pill near approval

the Pharmaceutical Benefits Advisory Committee recommended that two abortion drugs be added to the Pharmaceutical Benefits Scheme. Health Minister Tanya Plibersek thinks the listing of the RU486 drug will be approved ahead of the September 2013 Federal ... [Published Zecco - Apr 28 2013]

Entities: Pharmaceutical Benefits Advisory Committee, Australia, Tanya Plibersek

First reported Apr 26 2013 - Updated Apr 26 2013 - 2 reports

Australian government weighs heavy subsidy for abortion pill RU-486

Health officials in Australia have recommended a heavy government subsidy for the abortifacient drug RU-486. Ignoring evidence regarding the health risks caused by the "abortion pill," the Pharmaceutical Benefits Advisory Committee released its recommendation ... [Published The Sydney News - Apr 26 2013]

Entities: Australian Government, Pharmaceutical Benefits Advisory Committee, Pro-Life, Abortion, Ignorance

First reported Apr 25 2013 - Updated Apr 25 2013 - 4 reports

$12 abortions - drug set to be subsidised

The Pharmaceutical Benefits Advisory Committee is widely expected on Friday to agree that controversial drug RU486 should be subsidised by the Federal Government.This would mean that within months, the price will drop from up to $800 to as little as $5.90 ... [Published The Sydney News - Apr 25 2013]

Entities: Abortion, Drugs, Pharmaceutical Benefits Advisory Committee, Misoprostol

Quotes

A spokesman for Health Minister Tanya Plibersek hit back, describing the paper as " flawed report containing errors, inaccuracies and a selective use of statistics"

Patients missing out on medication, say drug companies [Published Sydney Morning Herald - May 20 2013]

...new medicines on the PBS, but this report shows that the number of new PBS medicines listed last year was the lowest in 20 years," Dr Shaw said. "That's very alarming because it means many patients who need new treatments aren't getting access to them. Consumers expect better than that. Australia should be a country that can afford new medicines for patients. "This decline is not due to any fall in the number of new therapies being proposed by companies. It has been due to things like higher rejection rates at the Pharmaceutical Benefits Advisory Committee and delays in the listing process for new medicines. "The real challenge now is to ensure these multi-billion dollar savings are used to get new therapies to patients. "The rationale behind PBS reforms with successive governments was to drive savings in the off-patent market, and use those savings to list new medicines. Those savings have been delivered; the issue now is ensuring new medicines can be listed. "This report and the Government's own Budget last week; both confirm that PBS reforms implemented over the last decade are driving substantial savings for government and consumers." The Impact of further PBS reforms was commissioned by Medicines Australia and is available at"

Number of new PBS medicines hits 20-year low [Published Noodls - May 20 2013]

"This decline is not due to any fall in the number of new therapies being proposed by companies."

Big drop in new drugs on PBS (The West Australian) [Published West Australian - May 19 2013]

"The pharma industry in Australia appears to be in a negative cycle and GSK's results are a reflection of an industry trend" general manager of pharmaceuticals Geoff McDonald said

Bitter pill for GSK profits [Published Melbourne Age - May 14 2013]

More Content

sort by: Date \| Relevance
Medicines and the media: news reports of medici... [Published BMC - 20 hours ago]
Glaucoma Management: Real Issues Yet To be... [Published Mivision - May 20 2013]
Price disclosure delivers for Government [Published Pharmacy News - May 20 2013]
Patients missing out on medication, say drug co... [Published Sydney Morning Herald - May 20 2013]
Number of new PBS medicines hits 20-year low [Published Noodls - May 20 2013]
Big drop in new drugs on PBS (The West Austral... [Published West Australian - May 19 2013]
Budget in focus: Australian Government Budget 2... [Published Norton Rose - May 15 2013]
Bitter pill for GSK profits [Published Melbourne Age - May 14 2013]
Grampians' group echoes abortion pill PBS calls [Published ABC Online - May 14 2013]
Pharmacy history now on the net [Published Pharmacy News - May 13 2013]
Pharmacist threatens to quit over RU486 [Published Pharmacy News - May 13 2013]
A matter for women and their doctors? If only [Published ABC Online - May 12 2013]
Abortion pill boycott [Published Tasmania Mercury - May 11 2013]
Comparing apples, pears and hips: health ration... [Published Crikey Media - May 10 2013]
Australia’s Billion-Dollar Blind Spot [Published The Global Mail - May 10 2013]
Health and hospitals: where the parties stand [Published ABC Online - May 10 2013]
Sigma sticks with high dividend payout [Published Zecco - May 09 2013]
RU486, PBS debate goes on in Parliament [Published BigPond News - May 03 2013]
Pharma hospitality crackdown stalls [Published Australian Doctor - May 03 2013]
Breakthrough melanoma drug too expensive for te... [Published ABC Online - May 02 2013]
Melanoma drug only if you can afford it [Published Perth Now - May 01 2013]
Call for bulk-billed abortions [Published Daily Telegraph Australia - May 01 2013]
The decision to recommend PBS listing for RU486... [Published Crikey Media - May 01 2013]
Abortion drug caution urged [Published McPherson Media Group - Apr 29 2013]
Generic pricing “a second-order issue”: economist [Published Pharmacy News - Apr 29 2013]
PBAC recommendation no guarantee of PBS-listing... [Published Pharmacy News - Apr 29 2013]
RU-486: 'We must make sure we use it safely' [Published 6minutes.net.au - Apr 29 2013]
Recommendation By Drugs Benefits Committee Coul... [Published International Business Times UK - Apr 28 2013]
Q&A tweets Labor?s lines against Abbott [Published Brisbane Courier-Mail - Apr 28 2013]
Abortion pill near approval [Published Zecco - Apr 28 2013]

Blogs

sort by: Date \| Relevance
Australia Considers Dropping The Price Of First... [Published Think Progress - Apr 25 2013] Australia’s Pharmaceutical Benefits Advisory Committee is set to recommend on Friday that the country subsidize access to the RU-486 abortion pill, ensuring access to affordable reproductive choices for the vast majority of Australians. Australia’s ...
Australia's 'Fourth Hurdle' Drug Review Compari... [Published Health Affairs current issue - Apr 08 2013] Two decades ago Australia introduced an assessment of value as a prerequisite for adding new medicines to its national drug formulary. Australia’s program—a "fourth hurdle" process after a drug is assessed for safety, efficacy, and quality—stands in ...